No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 195-197

  Campbell, Ian G ^a   Eccles, Diana M ^b   Choong, David Y H ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b PRINCESS ANNE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Cancer predisposition; Case control study; MDM2 polymorphism; Ovarian cancer

Indexed keywords

PROTEIN MDM2;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 33746218700     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.003     Document Type: Article

References (7)

1. Bueso-Ramos C.E., Manshouri T., Haidar M.A., Yang Y., McCown P., Ordonez N., et al. Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res. Treat. 37 (1996) 179-188
2. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., and Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358 (1992) 80-83
3. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119 (2004) 591-602
4. Lundgren K., Montes de Oca Luna R., McNeill Y.B., Emerick E.P., Spencer B., Barfield C.R., et al. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev. 11 (1997) 714-725
5. Eccles D., Marlow A., Royle G., Collins A., and Morton N.E. Genetic epidemiology of early onset breast cancer. J. Med. Genet. 31 (1994) 944-949
6. Eccles D.M., Englefield P., Soulby M.A., and Campbell I.G. BRCA1 mutations in southern england. Br. J. Cancer 77 (1998) 2199-2203
7. Foulkes W.D., Stamp G.W., Afzal S., Lalani N., McFarlane C.P., Trowsdale J., et al. MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. Br. J. Cancer 72 (1995) 883-888